14 July 2017 | News
Before his appointment at GGC, Dr Turpaz was the CIO of Human Longevity Inc, where he led the development and implementation of the global cloud based informatics, analytics, and awards winning innovative solutions
Global Gene Corp (GGC), a UK based genomic data platform company announced that former Chief Information Officer (CIO) of Human Longevity Inc, Dr Yaron Turpaz will join the company as Chief Data and Technology Officer.
Dr Turpaz will also assume country management responsibility as Managing Director of GGC Singapore. He will be responsible for the enhancement and development of the company's global data and technology infrastructure, advance analytics, data sciences and machine learning, as well as the expansion of GGC's Asia operations at Singapore.
Dr Turpaz said, “leaders, scientists, engineers, clinicians and healthcare professionals. I look forward to contribute to the success and health of GGC's global customers, and lead a data and technology driven transformation of healthcare”
Sumit S Jamuar, CEO, Global Gene Corp said, “With over 17 years of experience in the fields of bioinformatics, pharmaceuticals, digital health and genomics, Dr Turpaz is an invaluable addition to the company's executive leadership team”
"I am delighted to welcome Dr Turpaz to my leadership team at Global Gene Corp. In addition to his complementary expertise and extensive industry experience, Dr. Turpaz is passionate about our mission and shares the value and ethos that drive us. I am looking forward to our journey together," he added
Before his appointment at GGC, Dr Turpaz was the CIO of Human Longevity Inc, where he led the development and implementation of the global cloud based informatics, analytics, and awards winning innovative solutions. He also established and led HLI's Asia operations. Prior to joining HLI, he held a VP, R&D IT role at AstraZeneca.